{
  "paper_metadata": {
    "pmid": "28632743",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on the KCNH2 variant N588K, including clinical significance, penetrance data, and individual records."
  },
  "variants": [
    {
      "gene_symbol": "KCNH2",
      "cdna_notation": "c.1763A>T",
      "protein_notation": "p.Asn588Lys",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "51-year-old male",
        "phenotype": "Short QT syndrome (SQT1) with a corrected QT interval (QTc) of 288 ms"
      },
      "penetrance_data": {
        "total_carriers_observed": null,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 51,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Short QT syndrome with a QTc of 288 ms",
          "evidence_sentence": "KCNH2-linked short QT syndrome (SQT1) was first identified in a 51-year-old male presenting a corrected QT interval (QTc) of 288 ms."
        }
      ],
      "functional_data": {
        "summary": "The N588K mutation leads to an increased activity of rapid delayed rectifier potassium current (IKr) in the hERG potassium channels, resulting in a substantial gain of function during phase 2 and 3 of the cardiac action potential.",
        "assays": [
          "in vitro standard whole-cell patch clamp recordings"
        ]
      },
      "segregation_data": "Not mentioned",
      "population_frequency": "Not mentioned",
      "evidence_level": "Strong evidence based on functional studies and clinical presentation.",
      "source_location": "Introduction, paragraph 3",
      "additional_notes": "The variant is associated with a significant clinical phenotype of SQT1.",
      "key_quotes": [
        "KCNH2-linked short QT syndrome (SQT1) was first identified in a 51-year-old male presenting a corrected QT interval (QTc) of 288 ms.",
        "Results from in vitro standard whole-cell patch clamp recordings have revealed that this mutation leads to an increased activity of rapid delayed rectifier potassium current (IKr) in the hERG potassium channels."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "The extraction was straightforward as the paper provided clear information on the KCNH2 variant."
  }
}